Sales & Marketing News | pharmaphorum

News

UDG Healthcare acquires Putnam Associates and Incisive Healt...

UDG Healthcare has boosted its Ashfield Communications and Advisory business with a brace of deals, acquiring Putnam Associates and Incisive Health for a total of $106 million.

News

Shingles vaccine boosts GSK as generic Advair bites

GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of declining Advair sales.

News

The Bloc Jennifer Matthews CEO president

The Bloc promotes Jennifer Matthews to CEO and president

New York-based healthcare creative agency The Bloc has promoted managing partner Jennifer Matthews to CEO and president.

News

FDA approves first medical device ADHD treatment

US regulators have given the green-light for the first medical device to treat attention deficit hyperactivity disorder (ADHD).

News

Catalent acquires gene therapy specialist Paragon for $1.2bn

Drug delivery technology provider Catalent is to acquire gene therapy company Paragon for $1.2 billion.

News

Mesoblast poised to file cell therapy for GVHD in US

Australian biotech Mesoblast can go ahead with a US filing for its off-the-shelf stem cell therapy for acute graft-versus-host disease (GVHD), after negotiations with the FDA.

UDG Healthcare acquires Putnam Associates and Incisive Healt...

Shingles vaccine boosts GSK as generic Advair bites

The Bloc promotes Jennifer Matthews to CEO and president

FDA approves first medical device ADHD treatment

Catalent acquires gene therapy specialist Paragon for $1.2bn

Mesoblast poised to file cell therapy for GVHD in US

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks